How many days does it take to be discharged from the hospital for Kawasaki disease?

Written by Li Jiao Yan
Neonatology
Updated on September 04, 2024
00:00
00:00

Kawasaki disease is a disease with unclear pathogenesis and etiology. A major pathological change is systemic vasculitis, which commonly affects the coronary arteries. Typically, it presents with fever lasting from seven to fourteen days or longer, and antibiotics are ineffective in treatment. During the first through sixth weeks of the illness, complications such as pericarditis, myocarditis, endocarditis, and arrhythmias may occur. Coronary artery damage often occurs between the second and fourth weeks of the illness, and proactive and effective treatment of Kawasaki disease can prevent coronary complications. The acute phase generally involves symptomatic supportive care, prevention of platelet aggregation, fever reduction, and prevention of coronary artery damage. Treatment with intravenous immunoglobulin is recommended within the first ten days of onset. If the treatment is not effective, other special medications like steroids may be used, and the treatment duration is generally between two to four weeks. Thus, the pathogenesis of Kawasaki disease is uncertain, and its pathological process is prolonged. The specific timing of discharge depends on the child's condition. If the fever is controlled and no significant coronary artery damage is evident, and the condition is stable, then discharge is possible. However, post-discharge, follow-up should be conducted based on the child's specific condition. Therefore, the duration of hospitalization for Kawasaki disease is not fixed and depends on the child's condition and treatment response.

Other Voices

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
46sec home-news-image

What should be paid attention to in the diet for Kawasaki disease?

Kawasaki disease is a type of mucocutaneous lymph node syndrome, and its main pathological change is systemic vasculitis. Its main characteristics include persistent fever, high fever, ineffective antibiotic treatment, followed by the appearance of a skin rash on the mucous membranes, accompanied by enlarged lymph nodes. When Kawasaki disease occurs, there is a high fever, so it is suggested that children with Kawasaki disease should consume a diet high in protein, calories, and fiber, which is light and easily digestible in liquid or semi-liquid form. Spicy, overly hard, and overly hot foods should be avoided.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 18sec home-news-image

Does Kawasaki disease cause vomiting?

Kawasaki disease is a disease with no clear etiology, commonly seen in infants and toddlers, with eighty percent of cases occurring in children under five years old. Its main pathological change is systemic vasculitis. The main symptoms include fever, congested and cracked lips, diffuse congestion of the oral mucosa, swollen tongue papillae, and strawberry tongue. Other symptoms may include swelling of the hands and feet, polymorphous erythema, and enlarged lymph nodes. There could be subsequent cardiac complications, primarily affecting the coronary arteries. Kawasaki disease may cause vomiting due to the diffuse congestion in the oral cavity, and the pharynx might also be congested. When children experience significant congestion, their laryngeal reflex might be sensitive, possibly leading to vomiting. Furthermore, children with Kawasaki disease might develop secondary infections from other bacteria and viruses, which could also lead to symptoms like vomiting. Therefore, the manifestations of Kawasaki disease can vary, and if significant vomiting occurs, it should be investigated to determine the cause.

doctor image
home-news-image
Written by Zeng Hai Jiang
Pediatrics
44sec home-news-image

Kawasaki Disease and Purpura Differences

The clinical manifestations of Kawasaki disease include fever lasting more than five days, ineffective antibiotic treatment, rashes, transient swelling of the cervical lymph nodes, conjunctival congestion, strawberry tongue, cracked lips, hard swelling of fingers and toes, and desquamation around the nails and anal region during the recovery phase. Allergic purpura is mainly manifested by rashes, which are generally hemorrhagic rashes below the buttocks, symmetrical on the lower limbs, raised above the skin surface, and usually without fever. Besides rashes, allergic purpura can also involve joint pain, abdominal pain, or allergic purpuric nephritis among other conditions.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
53sec home-news-image

The recurrence rate of Kawasaki disease

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a type of pediatric autoimmune disease that commonly affects infants and young children, especially those under the age of five. The exact mechanisms and causes of the disease are still unclear. The primary pathological change is systemic vasculitis, frequently affecting the coronary arteries. The recurrence rate of Kawasaki disease is between 1%-3%, with a few cases experiencing three or even four occurrences. The interval between recurrences ranges from three months to one year, averaging one year and five months. Studies have shown that being younger than three years old at the time of the first episode and having vascular damage are risk factors for recurrence.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 45sec home-news-image

Is Kawasaki disease easy to treat?

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a self-limiting disease but is an acute systemic vasculitis commonly seen in infants and children under the age of 5. The primary clinical manifestations include non-suppurative cervical lymphadenopathy, oral mucosal lesions, conjunctival congestion, prolonged fever, polymorphous rash, and hard swelling of the hands and feet with fingertip desquamation. Cardiovascular damage is the most severe complication of Kawasaki disease and can lead to coronary artery aneurysms and coronary artery dilation. If Kawasaki disease is not treated promptly, the incidence of developing coronary artery aneurysms is 15%-25%, making Kawasaki disease one of the most common causes of acquired heart disease in infants and young children. Therefore, timely treatment of Kawasaki disease is crucial, generally involving anti-inflammatory treatment, immune support, and symptomatic management. If there is no concomitant coronary artery damage, treatment involves symptomatic management. If there is coronary artery damage, the treatment duration will be longer and regular follow-up is necessary. The course of the disease can extend over months or even years, thus treatment of Kawasaki disease needs to be tailored based on the individual's condition and clinical symptoms.